Resources Contact Us Home
Purine derivatives as A3 and A1 adenosine receptor agonists

Image Number 5 for United States Patent #7825126.

Disclosed are (N)-methanocarba adenine nucleosides of the formula: ##STR00001## as highly potent A.sub.3 adenosine receptor agonists, pharmaceutical compositions comprising such nucleosides, and a method of use of these nucleosides, wherein R.sub.1-R.sub.6 are as defined in the specification. These nucleosides are contemplated for use in the treatment a number of diseases, for example, inflammation, cardiac ischemia, stroke, asthma, diabetes, and cardiac arrhythmias. The invention also provides compounds that are agonists of both A.sub.1 and A.sub.3 adenosine receptors for use in cardioprotection.

  Recently Added Patents
Transfer device and image forming apparatus including regulation member
High surface area composition for use in the catalytic hydroconversion of a heavy hydrocarbon feedstock, a method making such composition and its use
Power generating apparatus of renewable energy type and method of attaching and detaching blade
Light fixture
TC-83-derived alphavirus vectors, particles and methods
Transitional replacement of operations performed by a central hub
PLL circuit
  Randomly Featured Patents
Spindle motor and optical disc drive having the same
Bit-slice digital processor for correlation and convolution
Wearable vehicular signaling system adapted and augmented for wearing on or about the body of a person
Method of making a parallax barrier, parallax barrier and autostereoscopic display
Yarn finish formulations
Electrical connector
Power activating device
Tire pressure measurement system with reduced current consumption
Atomic command retry in a data storage system